![Charlotte Vedel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charlotte Vedel
Directeur/Membre du Conseil chez
CURASIGHT A/S
Fortune : 200 154 $ au 31/05/2026
Profil
Charlotte Vedel is the founder.
Dr. Vedel is the founder of Lactobio ApS.
Dr. Vedel is Chief Operating Officer at Lactobio ApS since 2017.
Dr. Vedel is Deputy Chairman at Curasight A since 2020.
Formerly, Dr. Vedel was Vice President-Research & Development at International N&H Denmark ApS from 2006 to 2017.
Formerly, Dr. Vedel was Chief Technology Officer at Novo Nordisk Fonden from 2017 to 2018.
Formerly, Dr. Vedel was Manager-Research & Development at Roche Innovation Center Copenhagen A from 2001 to 2003.
Education includes a graduate degree from the University of Ulster and graduate and doctorate degrees from the Technical University of Denmark.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CURASIGHT A/S 0,14% | 30/06/2025 | 69 289 ( 0,14% ) | 200 154 $ | 31/05/2026 |
Postes actifs de Charlotte Vedel
| Sociétés | Poste | Début |
|---|---|---|
| CURASIGHT A/S | Directeur/Membre du Conseil | 01/01/2020 |
Lactobio ApS | Fondateur | 01/08/2017 |
Anciens postes connus de Charlotte Vedel
| Sociétés | Poste | Fin |
|---|---|---|
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation | Directeur Technique/Scientifique/R&D | 01/01/2018 |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables Produces food enzymes, products and pharmaceutical grade excipients for food products | Directeur Technique/Scientifique/R&D | 01/01/2017 |
Roche Innovation Center Copenhagen A/S
 Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Directeur Technique/Scientifique/R&D | 01/01/2003 |
Formation de Charlotte Vedel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
22
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
International N&H Denmark ApS
International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables Produces food enzymes, products and pharmaceutical grade excipients for food products | Consumer Non-Durables |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation | Miscellaneous |
University of Ulster
 University of Ulster Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technical University of Denmark
 Technical University of Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Innovation Center Copenhagen A/S
Roche Innovation Center Copenhagen A/S Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for the treatment of oncology, metabolic diseases, and infectious diseases | Health Technology |
Curasight A/S
 Curasight A/S Medical SpecialtiesHealth Technology Provides PET imaging research techniques for prostate cancer | Health Technology |
Lactobio ApS |
